Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Corcept Therapeutics Inc. (CORT) has a market cap of $4.65B with year-over-year revenue growth of +39.9%. Net margin stands at 20.9%. The stock trades at a P/E ratio of 32.9.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, CORT posted revenue growth of +39.9% and trades at a P/E of 32.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.